title: Systemic progression following complete cutaneous remission under bexarotene treatment for tumor-stage mycosis fungoides.
authors.forename: Iris
authors.initials: I
authors.lastname: Amitay-Laish
authors.forename: Michael
authors.initials: M
authors.lastname: David
authors.forename: Emmilia
authors.initials: E
authors.lastname: Hodak
mesh_terms: D000077610:Bexarotene; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000473:pathology / Q000628:therapy*; D009361:Neoplasm Invasiveness / Q000473:pathology*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000473:pathology; D019233:Retreatment; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D013764:Tetrahydronaphthalenes / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013764:Tetrahydronaphthalenes; D000077610:Bexarotene